Noxopharm Limited announced the following senior appointments: Mr. Bhavin Raval has been appointed as Noxopharm Group Chief Financial Officer and Company Secretary (Nyrada); Dr. John Wilkinson has been appointed Noxopharm Chief Scientific Officer; Mr. James Bonnar has been appointed Vice-President, R&D (Nyrada); and Mr. Mark Waring has been appointed Senior Vice-President, US Operations (Nyrada).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 AUD | -.--% | +8.11% | +12.68% |
28/05 | Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7% | MT |
04/04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
1st Jan change | Capi. | |
---|---|---|
+12.68% | 1.55Cr | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Limited Announces Management Appointments